| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | For oral administration |
|
Still deciding? Get samples of US$ 100/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| About Us |
| DMS is a leading pharmaceutical Contract Development and Manufacturing Organizations (CDMO). DMS's Manufacturing Services supply several hundred different products in a variety of dosage forms including solid dose, semi solids, sterile (liquids, freeze dried,powder), beta-lactams, hormones, dry powder metered dose inhalers, oral liquids and granulates, from our facilities across the world. dmsdrugs.en.made-in-china.com |
| Product Name | Griseofulvin Tablets |
| Contians | Griseofulvin 500mg |
| Package | 100 tablets/box |
| Store | Store at 25°C (77°F); excursions permitted to 20 to 25°C (68 to 77°F) |
| Alloication | Griseofulvin is indicated for the treatment of dermatophyte infections of the skin not adequately treated by topical therapy, hair and nails, namely:. |
| DOSAGE AND ADMINISTRATION | |
| Accurate diagnosis of the infecting organism is essential. Identification should be made either by direct microscopic examination of a mounting of infected tissue in a solution of potassium hydroxide or by culture on an appropriate medium. Medication must be continued until the infecting organism is completely eradicated as indicated by appropriate clinical or laboratory examination. Representative treatment periods are tinea capitis, 4 to 6 weeks; tinea corporis, 2 to 4 weeks; tinea pedis, 4 to 8 weeks; tinea unguium - depending on rate of growth - fingernails, at least 4 months; toenails, at least 6 months. General measures in regard to hygiene should be observed to control sources of infection or reinfection. Concomitant use of appropriate topical agents is usually required, particularly in treatment of tinea pedis. In some forms of tinea pedis, yeasts and bacteria may be involved as well as dermatophytes. Griseofulvin will not eradicate these associated bacterial or yeast infections. ADULTS: 0.5 g daily (125 mg q.i.d., 250 mg b.i.d., or 500 mg/day). Patients with less severe or 300 extensive infections may require less, whereas those with widespread lesions may require a starting dose of 0.75 g to 1 g/day. This may be reduced gradually to 0.5 g or less after a response has been noted. In all cases, the dosage should be individualized. PEDIATRIC PATIENTS (older than 2 years): A dosage of 10 mg/kg daily is usually adequate (pediatric patients from 30 to 50 lb, 125 mg to 250 mg daily; pediatric patients over 50 lb, 250 mg to 500 mg daily, in divided doses). Dosage should be individualized, as with adults. Clinical relapse will occur if the medication is not continued until the infecting organism is eradicated. Safety is not established at higher doses than recommended. |
|
| WE CAN PROVIDE MAKE FORMEULATION (OEM) Service we can provide: 1. Mixed container, we can mix different items in one container. 2. Quality control, before shipment, free sample for test. After shipment, keep sample for 3 years 3. Prompt shipment with professional documents 4. Packing as your request, with photo before shipment. DMS CHEMICAL PHARMACEUTICAL INC.LTD http://dmsdrugs.en.made-in-china.com/ |
){kind=link}